PharMerica risk analysis

Use PharMerica Corporation risk analysis together with your other stock asset holdings to enhance returns of your portfolios as well as to check it against diversification policy that fits your risk preferences.  Optimize Portfolio

Projected Return Density against Market

Considering 30-days investment horizon, PharMerica has beta of 0.95 . This implies PharMerica Corporation market returns are very sensitive to returns on the market. As the market benchmark goes up or down, PharMerica is expected to follow. Moreover, PharMerica Corporation has alpha of 0.95 implying that it can potentially generate 0.95% excess return over S&P 500 after adjusting for the inherited market risk (beta).Considering 30-days investment horizon, the coefficient of variation of PharMerica is 470.14. The daily returns are destributed with a variance of 3.31 and standard deviation of 1.82. The mean deviation of PharMerica Corporation is currently at 1.23. For similar time horizon, the selected benchmark (S&P 500) has volatility of 0.55

	(alpha)	=	0.95	Details
	(beta)	=	0.95	Details
	(volatility)	=	1.82	Details

Actual Return Volatility

PharMerica Corporation has volatility of 1.82% on return distribution over 30 days investment horizon. S&P 500 shows 0.55% volatility of returns over 30 trading days.